Anti-BCMA and CD19 CART cells will be injected intravenously on a one-time basis.
SWKCART24031101
Unknown small_molecule active
Quick answer
Anti-BCMA and CD19 CART cells will be injected intravenously on a one-time basis. for Autoimmune Diseases is a Unknown program (small_molecule) at Xiyuan Hospital of China Academy of Chinese Medical Sciences with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Xiyuan Hospital of China Academy of Chinese Medical Sciences
- Indication
- Autoimmune Diseases
- Phase
- Unknown
- Modality
- small_molecule
- Status
- active